- Home
- FCCO vs GNLX Comparison
FCCO vs GNLX Comparison
Compare FCCO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCCO
- GNLX
- Stock Information
- Founded
- FCCO 1994
- GNLX 2001
- Country
- FCCO United States
- GNLX United States
- Employees
- FCCO N/A
- GNLX N/A
- Industry
- FCCO Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FCCO Finance
- GNLX Health Care
- Exchange
- FCCO Nasdaq
- GNLX Nasdaq
- Market Cap
- FCCO 222.9M
- GNLX 202.4M
- IPO Year
- FCCO 1998
- GNLX 2023
- Fundamental
- Price
- FCCO $27.65
- GNLX $5.24
- Analyst Decision
- FCCO Strong Buy
- GNLX Strong Buy
- Analyst Count
- FCCO 2
- GNLX 4
- Target Price
- FCCO $30.00
- GNLX $19.75
- AVG Volume (30 Days)
- FCCO 28.1K
- GNLX 344.1K
- Earning Date
- FCCO 10-22-2025
- GNLX 11-05-2025
- Dividend Yield
- FCCO 2.34%
- GNLX N/A
- EPS Growth
- FCCO 42.01
- GNLX N/A
- EPS
- FCCO 2.40
- GNLX N/A
- Revenue
- FCCO $74,180,000.00
- GNLX N/A
- Revenue This Year
- FCCO $22.64
- GNLX N/A
- Revenue Next Year
- FCCO $27.09
- GNLX N/A
- P/E Ratio
- FCCO $11.42
- GNLX N/A
- Revenue Growth
- FCCO 18.23
- GNLX N/A
- 52 Week Low
- FCCO $19.46
- GNLX $1.99
- 52 Week High
- FCCO $29.55
- GNLX $8.54
- Technical
- Relative Strength Index (RSI)
- FCCO 45.72
- GNLX 40.27
- Support Level
- FCCO $26.55
- GNLX $4.34
- Resistance Level
- FCCO $27.15
- GNLX $6.26
- Average True Range (ATR)
- FCCO 0.48
- GNLX 0.84
- MACD
- FCCO 0.06
- GNLX -0.33
- Stochastic Oscillator
- FCCO 32.83
- GNLX 21.61
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.